RFK jr: Drug developers pressing ahead with public listings despite concerns over health role
health
Pharmaceutical and health stocks have gyrated in the days since Donald Trump nominated Robert Kennedy as secretary of the US Department of Health and Human Services. Photo / Tom Brenner, The Washington Post Two drug developers are pressing ahead with Read more
Putin's Near Motionless Hands Reignite Health Rumors—What To Know
2024-11-22 MSN
Classroom Clinic brings mental health access to Iowa students
2024-11-22 KCCI Des Moines
Allina Health moves out of Humana's Medicare Advantage Network
2024-11-23 KSTP-TV
Nearly 3,000 residents from major Philly health systems are unionizing
2024-11-21 Philadelphia Inquirer
From vaccines to abortion: Why RFK Jr. faces a bruising fight in becoming Trump's health secretary
2024-11-21 MSN
Wendy Williams 'incapacitated': What we know about her health
2024-11-27 KDFW
Under fire health secretary Neil Gray told to 'come clean' after it emerged he took an official limo to movie bash
2024-11-26 Daily Mail
Hub to tackle health issues could 'change lives'
2024-11-26 BBC on MSN.com
Fiji underinvesting in its health sector: Report
2024-11-28 fbcnews
Patients to pay as hospitals axe health-insurer deals
2024-11-22 South Coast Register